A critical discovery in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently inactivated in various forms of malignancies, https://socialmphl.com/story24294934/mini-antibodies-restore-the-p53-protein-new-promising-approach-for-tumor-therapy